Internal Medicine, Endocrinology, Diabetes, & Metabolism · Atlanta, GA
NPI
1659378560
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1800 Howell Mill Rd NW, Suite 450
Atlanta, GA, 30318
Phone (404) 355-4393
Groups this clinician bills Medicare through
Medicare paid, 2024
$351K
15,518 services
Medicare patients, 2024
788
Average age 72
Drug cost, 2024
$2.8M
6,753 prescriptions
Company payments, 2025
$190K
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David G Robertson was code J0897 (injection, denosumab, 1 mg), 4,140 times for 41 patients. In total David G Robertson billed 15,518 services in 63 codes, and Medicare paid $351K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,140 | 41 | $20.36 | $84K |
| 99214 Office E&M - Established | Office | 1,175 | 564 | $96.43 | $113K |
| 83036 Blood Count | Office | 755 | 352 | $9.45 | $7,133 |
| 82948 Clinical Chemistry | Office | 506 | 256 | $4.91 | $2,486 |
| 84439 Clinical Chemistry | Office | 459 | 272 | $8.84 | $4,058 |
| 84443 Clinical Chemistry | Office | 447 | 278 | $16.46 | $7,358 |
| 95251 Test - Miscellaneous | Office | 362 | 144 | $26.91 | $9,742 |
| 84481 Clinical Chemistry | Office | 359 | 218 | $16.60 | $5,959 |
| 80061 Clinical Chemistry | Office | 240 | 169 | $13.08 | $3,140 |
| 99213 Office E&M - Established | Office | 203 | 145 | $72.06 | $15K |
| 36415 Venipuncture Blood Collection | Office | 161 | 130 | $8.60 | $1,385 |
| 99231 Hospital E&M - Subsequent | Facility | 158 | 93 | $39.68 | $6,269 |
| 99232 Hospital E&M - Subsequent | Facility | 154 | 89 | $62.05 | $9,556 |
| 80053 Clinical Chemistry | Office | 131 | 121 | $10.35 | $1,356 |
| 82570 Clinical Chemistry | Office | 123 | 105 | $5.08 | $625 |
By year: 2022 $371K for 25,224 services; 2023 $368K for 20,260 services; 2024 $351K for 15,518 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 755 | 352 | $9.45 | $7,133 |
| 82948 Clinical Chemistry | 506 | 256 | $4.91 | $2,486 |
| 84439 Clinical Chemistry | 459 | 272 | $8.84 | $4,058 |
| 84443 Clinical Chemistry | 447 | 278 | $16.46 | $7,358 |
| 84481 Clinical Chemistry | 359 | 218 | $16.60 | $5,959 |
| 80061 Clinical Chemistry | 240 | 169 | $13.08 | $3,140 |
| 36415 Venipuncture Blood Collection | 161 | 130 | $8.60 | $1,385 |
| 80053 Clinical Chemistry | 131 | 121 | $10.35 | $1,356 |
| 82570 Clinical Chemistry | 123 | 105 | $5.08 | $625 |
| 82043 Clinical Chemistry | 123 | 104 | $5.66 | $696 |
Medicare prescription drug claims, 2024
In 2024, the drug David G Robertson prescribed most often to Medicare patients was Levothyroxine Sodium, with 579 prescriptions and refills. In total David G Robertson wrote 6,753 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 579 | 1,524 | 177 | $6,407 |
| Synthroid Levothyroxine Sodium | 384 | 844 | 81 | $34K |
| Ozempic Semaglutide | 202 | 364 | 59 | $346K |
| Mounjaro Tirzepatide | 173 | 232 | 32 | $242K |
| Trulicity Dulaglutide | 165 | 268 | 32 | $264K |
| Amlodipine Besylate Generic | 155 | 352 | 42 | $819 |
| Jardiance Empagliflozin | 151 | 331 | 40 | $190K |
| Liothyronine Sodium Generic | 146 | 384 | 43 | $7,028 |
| Atorvastatin Calcium Generic | 144 | 399 | 50 | $1,133 |
| Metformin Hcl Generic | 114 | 322 | 39 | $676 |
| Rosuvastatin Calcium Generic | 105 | 305 | 36 | $1,666 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 103 | 210 | 42 | $9,444 |
| Hydrocortisone Generic | 101 | 211 | 32 | $5,963 |
| Unithroid Levothyroxine Sodium | 92 | 196 | 23 | $1,524 |
| Farxiga Dapagliflozin Propanediol | 92 | 215 | 27 | $109K |
Brand drugs: 2,766 claims; generic drugs: 3,646 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David G Robertson $190K ($190K in general payments such as food, travel and fees) from 32 companies. The largest payer was Lilly USA, LLC with $91K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 162 | $91K |
| Novo Nordisk Inc NVO | 62 | $47K |
| Sanofi-Aventis U.S. LLC SNY | 23 | $24K |
| Acella Pharmaceuticals, LLC | 4 | $23K |
| Xeris Pharmaceuticals, Inc. | 8 | $2,519 |
| Amgen Inc. AMGN | 13 | $244 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $238 |
| Mannkind Corporation MNKD | 7 | $171 |
| Abbott Laboratories ABT | 6 | $108 |
| Recordati_rare_diseases_inc. | 5 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.